作者:
Reguart,N. [1]
;
Rosell,R. [2]
;
Cardenal,F. [3]
;
Cardona,A.F. [4]
;
Isla,D. [5]
;
Palmero,R. [6]
;
Moran,T. [7]
;
Rolfo,C. [8]
;
Pallarès,M.C. [9]
;
Insa,A. [10]
;
Carcereny,E. ;
Majem,M. ;
DeCastro,J. ;
Queralt,C. ;
Molina,M.A. ;
Taron,M.
作者单位:
Medical Oncology Department, Hospital Clínico Lozano Blesa, Zaragoza, Spain
[1]
Pangaea Biotech, Hospital Universitario Quirón, Dexeus, Barcelona, Spain
[2]
Medical Oncology Department, Hospital Germans Trías i Pujol, Institut Català d'Oncologia-ICO
[3]
Medical Oncology Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
[4]
Medical Oncology Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia
[5]
Medical Oncology Department, Centre Sanitari i Universitari de Bellvitge, Institut Català d
[6]
Phase I, Early Clinical Trials Unit, University Hospital of Antwerp-UZA, Belgium
[7]
Medical Oncology Department, Hospital La Paz, Madrid, Spain
[8]
Medical Oncology Department, Hospital Clínico Universitario, Valencia, Spain
[9]
Medical Oncology Department, Hospital Clinic Barcelona-ICMHO, Barcelona, Spain
[10]
发布时间
2014-07-31